Comprehensive Stock Analysis of CF Industries Holdings, Inc.(NYSE:CF): Ionis Pharmaceuticals, Inc.(NASDAQ:IONS)

0
35

CF Industries Holdings, Inc. (CF) will report its next earnings on May 01 AMC. The company reported the earnings of $0.27/Share in the last quarter where the estimated EPS by analysts was $0.35/share. The difference between the expected and actual EPS was $-0.08/share, which represents an Earnings surprise of -22.9%.

Many analysts are providing their Estimated Earnings analysis for CF Industries Holdings, Inc. and for the current quarter 14 analysts have projected that the stock could give an Average Earnings estimate of $0.88/share. These analysts have also projected a Low Estimate of $0.61/share and a High Estimate of $1.15/share.

In case of Revenue Estimates, 11 analysts have provided their consensus Average Revenue Estimates for CF Industries Holdings, Inc. as 1.44 Billion. According to these analysts, the Low Revenue Estimate for CF Industries Holdings, Inc. is 1.28 Billion and the High Revenue Estimate is 1.55 Billion. The company had Year Ago Sales of 1.3 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for CF to be 6.4%. They are projecting Next Quarter growth of 115.38%. For the next 5 years, CF Industries Holdings, Inc. is expecting Growth of 28.14% per annum, whereas in the past 5 years the growth was 60.48% per annum.

Some buy side analysts are also providing their Analysis on CF Industries Holdings, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 3 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for CF Industries Holdings, Inc. might touch $60 high while the Average Price Target and Low price Target is $49.72 and $38 respectively.

CF Industries Holdings, Inc. closed its last trading session at $41.92 with the gain of 1.98%. The Market Capitalization of the company stands at 9.55 Billion. The Company has 52-week high of $56.51 and 52-week low of $38.90. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.45% where SMA50 and SMA200 are 0.74% and -6.43% respectively. The Company Touched its 52-Week High on 10/04/18 and 52-Week Low on 03/08/19.

The Relative Volume of the company is 1.09 and Average Volume (3 months) is 2.67 million. The company’s P/E (price to earnings) ratio is 29.69 and Forward P/E ratio of 15.63.

The company shows its Return on Assets (ROA) value of 2.5%. The Return on Equity (ROE) value stands at 9.8%. While it’s Return on Investment (ROI) value is 8.7%.

While looking at the Stock’s Performance, CF Industries Holdings, Inc. currently shows a Weekly Performance of 3.89%, where Monthly Performance is -2.53%, Quarterly performance is 0.49%, 6 Months performance is -16.62% and yearly performance percentage is 2.42%. Year to Date performance value (YTD perf) value is -1.75%. The Stock currently has a Weekly Volatility of 2.82% and Monthly Volatility of 3.07%.

Ionis Pharmaceuticals, Inc. (IONS) will report its next earnings on May 09 BMO. The company reported the earnings of $0.62/Share in the last quarter where the estimated EPS by analysts was $0.59/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 5.1%.

Many analysts are providing their Estimated Earnings analysis for Ionis Pharmaceuticals, Inc. and for the current quarter 15 analysts have projected that the stock could give an Average Earnings estimate of $-0.26/share. These analysts have also projected a Low Estimate of $-0.5/share and a High Estimate of $0/share.

In case of Revenue Estimates, 13 analysts have provided their consensus Average Revenue Estimates for Ionis Pharmaceuticals, Inc. as 148.86 Million. According to these analysts, the Low Revenue Estimate for Ionis Pharmaceuticals, Inc. is 126 Million and the High Revenue Estimate is 193.1 Million. The company had Year Ago Sales of 117.75 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for IONS to be -500%. They are projecting Next Quarter growth of -933.33%. For the next 5 years, Ionis Pharmaceuticals, Inc. is expecting Growth of 508.58% per annum, whereas in the past 5 years the growth was -103.72% per annum.

Some buy side analysts are also providing their Analysis on Ionis Pharmaceuticals, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 1 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Ionis Pharmaceuticals, Inc. might touch $106 high while the Average Price Target and Low price Target is $68.07 and $19 respectively.

Ionis Pharmaceuticals, Inc. closed its last trading session at $66.55 with the gain of 1.85%. The Market Capitalization of the company stands at 9.21 Billion. The Company has 52-week high of $86.58 and 52-week low of $40.91. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -5.11% where SMA50 and SMA200 are -11.32% and 15.97% respectively. The Company Touched its 52-Week High on 04/08/19 and 52-Week Low on 06/28/18.

The Relative Volume of the company is 0.73 and Average Volume (3 months) is 1.35 million. The company’s P/E (price to earnings) ratio is 26.24 and Forward P/E ratio of 172.47.

The company shows its Return on Assets (ROA) value of 14.4%. The Return on Equity (ROE) value stands at 39.3%. While it’s Return on Investment (ROI) value is 13.6%.

While looking at the Stock’s Performance, Ionis Pharmaceuticals, Inc. currently shows a Weekly Performance of 0.62%, where Monthly Performance is -18.61%, Quarterly performance is 15.14%, 6 Months performance is 34.89% and yearly performance percentage is 52.69%. Year to Date performance value (YTD perf) value is 25.38%. The Stock currently has a Weekly Volatility of 3.14% and Monthly Volatility of 4.28%.

SHARE